MDXH (MDxHealth) Current Ratio: 1.63 (As of Mar. 2026) — 28% Below Median


MDXH MDxHealth SA MDXH
45 GF Score
Price $0.44
GF Value $2.20
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is MDxHealth Current Ratio?

MDxHealth MDXH -6.12% 45 Current Ratio is 1.63 as of Mar. 2026, which is 28% below its 10-year median of 2.25. GuruFocus rates MDXH with a GF Score™ of 45/100 and a GF Value™ of $2.20 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, MDxHealth ranks worse than 59.35% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. MDxHealth's current ratio for the quarter that ended in Mar. 2026 was 1.63.

MDxHealth has a current ratio of 1.63. It generally indicates good short-term financial strength.

The historical rank and industry rank for MDxHealth's Current Ratio or its related term are showing as below:

MDXH' s Current Ratio Range Over the Past 10 Years
Min: 0.91   Med: 2.25   Max: 5.62
Current: 1.63

During the past 13 years, MDxHealth's highest Current Ratio was 5.62. The lowest was 0.91. And the median was 2.25.

MDXH's Current Ratio is ranked worse than
59.35% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.99 vs MDXH: 1.63

MDxHealth  (NAS:MDXH) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


MDxHealth Current Ratio Related Terms


MDxHealth Current Ratio Historical Data

* Premium members only.

The historical data trend for MDxHealth's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MDxHealth Current Ratio Chart

MDxHealth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.05 1.59 1.95 1.57 1.08

MDxHealth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 1.31 1.14 1.08 1.63

MDXH vs AWHL, BIOQ, XWEL: Current Ratio Comparison

For the Diagnostics & Research subindustry, MDxHealth's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MDxHealth Current Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, MDxHealth's Current Ratio distribution charts can be found below:

* The bar in red indicates where MDxHealth's Current Ratio falls into.


MDXH
45GF Score
MDxHealth SA MDXH
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MDxHealth Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

MDxHealth's Current Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Current Ratio (A: Dec. 2025 )=Total Current Assets (A: Dec. 2025 )/Total Current Liabilities (A: Dec. 2025 )
=53.409/49.534
=1.08

MDxHealth's Current Ratio for the quarter that ended in Mar. 2026 is calculated as

Current Ratio (Q: Mar. 2026 )=Total Current Assets (Q: Mar. 2026 )/Total Current Liabilities (Q: Mar. 2026 )
=67.893/41.577
=1.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 1.63 mean?
MDxHealth (MDXH) has a Current Ratio of 1.63 as of Mar. 2026. This is 28% below median its historical median of 2.25. Over the past decade, MDxHealth's Current Ratio has ranged from 0.91 to 5.62. According to the industry distribution chart, MDxHealth ranks #127 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 59.3%.
Is MDxHealth's Current Ratio too high?
MDxHealth's current Current Ratio of 1.63 is 28% below median its 10-year median of 2.25. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 5.62. The Medical Diagnostics & Research industry median Current Ratio is 1.99. MDxHealth's value of 1.63 is 18.1% below this industry median. Based on the distribution chart, MDxHealth ranks #127 out of 214 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, MDxHealth has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MDxHealth's Current Ratio compare to AWHL and BIOQ?
According to the Medical Diagnostics & Research industry distribution chart, MDxHealth ranks #127 out of 214 companies for Current Ratio. This places MDxHealth in the lower half of its industry. The industry median Current Ratio is 1.99. MDxHealth's value of 1.63 is 18.1% below this benchmark. Historically, MDxHealth's own Current Ratio has ranged from 0.91 to 5.62 over the past decade. While the company's 10-year median is 2.25 vs. the industry median of 1.99, MDxHealth has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 1.99, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MDxHealth's current Current Ratio of 1.63 is 18.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MDxHealth's current Current Ratio is 1.63, which is 28% below median its own 10-year median of 2.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MDxHealth stock overvalued right now?
Based on GuruFocus' analysis, MDxHealth (MDXH) is currently considered Possible Value Trap. The stock's GF Value™ is $2.20, compared to a current price of $0.44 — trading 79.8% below its estimated fair value. The current Current Ratio is 1.63, which is 28% below median its 10-year median of 2.25 and 18.1% below the Medical Diagnostics & Research industry median of 1.99. MDxHealth's overall GF Score™ is 45/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For MDxHealth (MDXH), the current Current Ratio is 1.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MDxHealth (MDXH) Overvalued in 2026?

Based on GuruFocus' analysis, MDxHealth stock appears to be undervalued. The current stock price of $0.44 is trading 79.8% below its estimated GF Value™ of $2.20. GuruFocus considers MDxHealth to be Possible Value Trap.

Key valuation signals for MDXH:

  • Current Ratio: 1.63 (28% below median its 10-year median of 2.25)
  • GF Value™: $2.20 vs. price of $0.44 (79.8% below fair value)
  • GF Score™: 45/100 with 5 warning signs
  • Industry Position: 18.1% below the Medical Diagnostics & Research median (#127 of 214)

No single metric tells the full story. See the MDXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MDxHealth Business Description

Other Exchanges O6C1:Germany
Address Zone Industrielle des Hauts-Sarts, Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
45GF Score

Get the complete analysis for MDXH

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price
$2.20
GF Value